The University of Chicago Header Logo

Amelia Kellar

Concepts (70)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Crohn Disease
13
2026
809
3.430
Why?
Colitis, Ulcerative
6
2025
800
2.120
Why?
Inflammatory Bowel Diseases
7
2025
647
1.960
Why?
Ultrasonography
10
2026
747
1.520
Why?
Intestines
5
2026
432
1.260
Why?
Remission Induction
5
2025
750
1.200
Why?
Mesentery
2
2026
47
1.190
Why?
Adipose Tissue
2
2026
272
1.000
Why?
Gastroenterologists
1
2022
31
0.730
Why?
Fat Necrosis
1
2017
6
0.540
Why?
Panniculitis
1
2017
11
0.540
Why?
Subcutaneous Fat
1
2017
21
0.530
Why?
Decision Support Techniques
1
2019
186
0.530
Why?
Hypocalcemia
1
2017
43
0.530
Why?
Child
8
2026
7621
0.520
Why?
Point-of-Care Systems
2
2026
156
0.400
Why?
Gastrointestinal Agents
2
2025
183
0.380
Why?
Adolescent
7
2026
9878
0.360
Why?
Severity of Illness Index
5
2026
1982
0.350
Why?
Colon
2
2026
540
0.310
Why?
Colonoscopy
2
2023
304
0.290
Why?
Disease Models, Animal
1
2015
2534
0.270
Why?
Retrospective Studies
6
2025
10307
0.270
Why?
Humans
18
2026
95992
0.260
Why?
Female
12
2026
49980
0.250
Why?
Ileum
3
2024
169
0.240
Why?
Male
11
2026
45792
0.230
Why?
Heterocyclic Compounds, 3-Ring
1
2024
44
0.210
Why?
Reference Values
1
2025
675
0.210
Why?
Reproducibility of Results
2
2026
2885
0.190
Why?
Lung Neoplasms
1
2015
2384
0.190
Why?
Drug Therapy, Combination
1
2024
789
0.180
Why?
Biological Products
1
2024
179
0.170
Why?
Anorexia
1
2021
28
0.170
Why?
Feces
1
2022
360
0.160
Why?
Consensus
1
2022
372
0.160
Why?
Exanthema
1
2021
40
0.160
Why?
Young Adult
4
2026
7034
0.160
Why?
Biomarkers
1
2026
1931
0.150
Why?
Predictive Value of Tests
2
2024
1819
0.150
Why?
Endoscopy, Gastrointestinal
1
2019
161
0.140
Why?
Adalimumab
1
2017
92
0.130
Why?
Treatment Outcome
3
2025
9228
0.130
Why?
Clinical Trials as Topic
2
2023
1166
0.110
Why?
Databases, Factual
1
2019
1014
0.110
Why?
Postoperative Complications
1
2026
2603
0.110
Why?
Skin
1
2017
604
0.100
Why?
Infant, Newborn
1
2017
2611
0.090
Why?
Cross-Sectional Studies
2
2026
1880
0.070
Why?
ROC Curve
2
2023
799
0.070
Why?
Postoperative Period
1
2026
318
0.060
Why?
Anastomosis, Surgical
1
2026
284
0.050
Why?
Infliximab
1
2025
163
0.050
Why?
Janus Kinase Inhibitors
1
2024
29
0.050
Why?
Biological Therapy
1
2024
47
0.050
Why?
Antineoplastic Agents
1
2015
2385
0.050
Why?
C-Reactive Protein
1
2024
206
0.050
Why?
Recurrence
1
2026
1231
0.050
Why?
Prospective Studies
2
2024
4690
0.050
Why?
Pregnancy Complications
1
2025
355
0.050
Why?
Mice
1
2015
12525
0.040
Why?
Longitudinal Studies
1
2024
1176
0.040
Why?
Motor Skills
1
2021
80
0.040
Why?
Adult
3
2026
28636
0.040
Why?
Sensitivity and Specificity
1
2023
2042
0.040
Why?
Pregnancy
1
2025
3239
0.030
Why?
Animals
1
2015
28901
0.030
Why?
Infant
1
2021
3359
0.030
Why?
Logistic Models
1
2017
1273
0.030
Why?
Middle Aged
2
2026
28299
0.020
Why?
Kellar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_